These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35170265)

  • 1. Advances in point-of-care platforms for traumatic brain injury: recent developments in diagnostics.
    Habli Z; Kobeissy F; Khraiche ML
    Rev Neurosci; 2022 Apr; 33(3):327-345. PubMed ID: 35170265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Label-free, ultrasensitive and rapid detection of FDA-approved TBI specific UCHL1 biomarker in plasma using MWCNT-PPY nanocomposite as bio-electrical transducer: A step closer to point-of-care diagnosis of TBI.
    Supraja P; Tripathy S; Krishna Vanjari SR; Singh SG
    Biosens Bioelectron; 2022 Nov; 216():114631. PubMed ID: 35973277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: Emerging Eye-Based Diagnostic Technologies for Traumatic Brain Injury.
    Harris G; Rickard JJS; Butt G; Kelleher L; Blanch RJ; Cooper J; Oppenheimer PG
    IEEE Rev Biomed Eng; 2023; 16():530-559. PubMed ID: 35320105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lab-on-a-Disc for Point-of-Care Infection Diagnostics.
    Sunkara V; Kumar S; Sabaté Del Río J; Kim I; Cho YK
    Acc Chem Res; 2021 Oct; 54(19):3643-3655. PubMed ID: 34516092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward development of clinically translatable diagnostic and prognostic metrics of traumatic brain injury using animal models: A review and a look forward.
    Hajiaghamemar M; Seidi M; Oeur RA; Margulies SS
    Exp Neurol; 2019 Aug; 318():101-123. PubMed ID: 31055005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic-integrated biosensors: prospects for point-of-care diagnostics.
    Kumar S; Kumar S; Ali MA; Anand P; Agrawal VV; John R; Maji S; Malhotra BD
    Biotechnol J; 2013 Nov; 8(11):1267-79. PubMed ID: 24019250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical Markers of Traumatic Brain Injury: Relevance to Acute Diagnostics, Disease Monitoring, and Neuropsychiatric Outcome Prediction.
    Shahim P; Zetterberg H
    Biol Psychiatry; 2022 Mar; 91(5):405-412. PubMed ID: 34857362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. μDrop: Multi-analyte portable electrochemical-sensing device for blood-based detection of cleaved tau and neuron filament light in traumatic brain injury patients.
    Khetani S; Singh A; Besler B; Butterworth S; Lijnse T; Loughery K; Smith K; Hosseini E; Narang R; Karan K; Debert C; Sen A; Murari K; Nezhad AS
    Biosens Bioelectron; 2021 Apr; 178():113033. PubMed ID: 33517230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-based traumatic brain injury biomarkers - Clinical utilities and regulatory pathways in the United States, Europe and Canada.
    Wang KK; Munoz Pareja JC; Mondello S; Diaz-Arrastia R; Wellington C; Kenney K; Puccio AM; Hutchison J; McKinnon N; Okonkwo DO; Yang Z; Kobeissy F; Tyndall JA; Büki A; Czeiter E; Pareja Zabala MC; Gandham N; Berman R
    Expert Rev Mol Diagn; 2021 Dec; 21(12):1303-1321. PubMed ID: 34783274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors.
    Alawieh H; Chemaly TE; Alam S; Khraiche M
    Sensors (Basel); 2019 Nov; 19(22):. PubMed ID: 31744130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Future of Nanotechnology-Driven Electrochemical and Electrical Point-of-Care Devices and Diagnostic Tests.
    Boukherroub R; Szunerits S
    Annu Rev Anal Chem (Palo Alto Calif); 2024 Jul; 17(1):173-195. PubMed ID: 39018353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Biosensor Technologies for Acute Kidney Injury.
    Derin E; Inci F
    ACS Sens; 2022 Feb; 7(2):358-385. PubMed ID: 34928578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in point-of-care technologies for molecular diagnostics.
    Zarei M
    Biosens Bioelectron; 2017 Dec; 98():494-506. PubMed ID: 28728010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Current State of Traumatic Brain Injury Biomarker Measurement Methods.
    Krausz AD; Korley FK; Burns MA
    Biosensors (Basel); 2021 Sep; 11(9):. PubMed ID: 34562909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic Detection of Traumatic Brain Injury Related Biomarkers.
    Cardinell BA; La Belle JT
    Methods Mol Biol; 2017; 1572():89-112. PubMed ID: 28299683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traumatic brain injury: classification, models, and markers.
    Najem D; Rennie K; Ribecco-Lutkiewicz M; Ly D; Haukenfrers J; Liu Q; Nzau M; Fraser DD; Bani-Yaghoub M
    Biochem Cell Biol; 2018 Aug; 96(4):391-406. PubMed ID: 29370536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Biomarker Detection Following Traumatic Brain Injury.
    Cardinell BA; Addington CP; Stabenfeldt SE; La Belle JT
    Crit Rev Biomed Eng; 2019; 47(3):193-206. PubMed ID: 31679255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care diagnostics for sepsis using clinical biomarkers and microfluidic technology.
    Bradley Z; Bhalla N
    Biosens Bioelectron; 2023 May; 227():115181. PubMed ID: 36867959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in point-of-care diagnostics for oral cancer.
    Kaur J; Srivastava R; Borse V
    Biosens Bioelectron; 2021 Apr; 178():112995. PubMed ID: 33515983
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.